Intest Res.  2022 Apr;20(2):157-158. 10.5217/ir.2022.00041.

Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?

• Park YE

• KMID: 2529560
• DOI: http://doi.org/10.5217/ir.2022.00041

Reference

1. Kim JM, Cheon JH. Pathogenesis and clinical perspectives of extraintestinal manifestations in inflammatory bowel diseases. Intest Res. 2020; 18:249–264.

2. Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013; 382:1587–1599.

3. Weng MT, Shih IL, Tung CC, et al. Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease. Intest Res. 2022; 20:224–230.

4. Mehta TI, Weissman S, Fung BM, Sotiriadis J, Lindor KD, Tabibian JH. Global incidence, prevalence and features of primary sclerosing cholangitis: a systematic review and meta-analysis. Liver Int. 2021; 41:2418–2426.

5. Song EM, Yang SK. Natural history of inflammatory bowel disease: a comparison between the East and the West. Intest Res. 2021; Dec. 2. [Epub]. https://doi.org/10.5217/ir.2021.00104.

6. de Vries AB, Janse M, Blokzijl H, Weersma RK. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. World J Gastroenterol. 2015; 21:1956–1971.

7. Ricciuto A, Kamath BM, Griffiths AM. The IBD and PSC phenotypes of PSC-IBD. Curr Gastroenterol Rep. 2018; 20:16.

8. Ostadmohammadi S, Azimirad M, Houri H, et al. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls. Mol Biol Rep. 2021; 48:5519–5529.

9. Low D, Swarup N, Okada T, Mizoguchi E. Landscape of inflammatory bowel disease in Singapore. Intest Res. 2022; Jan. 7. [Epub]. https://doi.org/10.5217/ir.2021.00089.

10. Caron B, Peyrin-Biroulet L, Pariente B, et al. Vedolizumab therapy is ineffective for primary sclerosing cholangitis in patients with inflammatory bowel disease: a GETAID multicentre cohort study. J Crohns Colitis. 2019; 13:1239–1247.